Skip to navigation Skip to main content

Featured Articles

Secondary Hemophagocytic Lymphohistiocytosis Following Dostarlimab Treatment in a Patient With Metastatic Endometrial Cancer

World Journal of Oncology

Volume 15, Number 5, October 2024, pages 844-850

By Emilie Rollet et al.

Potential Use of MicroRNA Technology in Thalassemia Therapy

Journal of Clinical Medicine Research

Volume 16, Number 9, Sept 2024, pages 411-422

By Lantip Rujito et al.

Impact of Lymph Node Dissection for Patients With Clinically Node-Negative Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study

World Journal of Oncology

Volume 15, Number 4, August 2024, pages 579-591

By Meng Sha et al.

Tonsillar Diffuse Large B-Cell Lymphoma of Non-Germinal Center Type With Cluster of Differentiation 5 Positive in a Pediatric Girl

Journal of Medical Cases

Volume 15, Number 11, November 2024, pages 324-329

By Ibrahim Alharbi et al.

Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation

Journal of Hematology

Volume 13, Number 5, October 2024, pages 229-237

By Lane Lerner et al.

Our Mission

Since 2008, ElmerPress strives to provide the international academic community with maximized quality scientific information throughout a wide spectrum of disciplines. ElmerPress understands how hard, and rigorously scientific information is obtained while relentlessly ensuring it is delivered in the quality and urgency it needs and deserves.


Through Peer-Reviewing, Editing, and Publishing, ElmerPress is committed to making sure every scientific discovery is heard with accuracy, presentability, and appropriate credibility. Our Open Access Journals published by ElmerPress are both Peer-Reviewed, and International, dedicated to the rapid academic exchange. The Publisher currently publishes 14 Open Access Medical Journals, focusing on Clinical Medicine Research in various disciplines.

The single most important criterion for acceptance is the originality of the work. However, a
To contact us for publishing inquiries, please reach out to our journals.
Browse Our Journals                     
A Message from Director and CEO                 

Company Profile

ElmerPress is a medical publishing company based in Toronto, Canada, founded in 2008. With over a decade of experience in the industry, we have established ourselves as a leading provider of high-quality publishing services to clients worldwide. Our team of experienced editors, designers, and project managers work closely with authors, researchers, and publishers to produce medical books, journals, and other publications that are both informative and engaging.


At ElmerPress, we are committed to maintaining the highest standards of quality and professionalism in all our work. We use the latest technology and best practices in the industry to ensure that our clients receive the best possible service and results. Whether you are an author, publisher, or researcher, we are dedicated to helping you achieve your goals and share your work with the world.

Why Choose Us?
Choose ElmerPress for your medical publishing needs to benefit from our decade-long experience in the industry, as well as our commitment to quality and excellence. With a focus on open access and peer-reviewed publications, we offer a range of services to help authors share their research with a global audience.
Seamless Publishing
Our publishing process ensures that you can deliver your research as fast as possible with the quality it deserves.
Our History and Values
Since 2008, ElmerPress has been dedicated to advancing the field of medicine through open access, peer-reviewed publications. We strive to be a reliable partner for authors and readers alike, providing a platform for valuable research to be shared and accessed by a global audience.
Our Committment to Continuous Improvement and Changing Needs
At ElmerPress, we are constantly evolving to meet the changing needs of the medical publishing industry. We invest in cutting-edge technology and stay up-to-date on the latest trends and innovations. Our commitment to continuous improvement allows us to deliver better results and provide an even more seamless experience for our authors and readers